Latest Regulatory Approval News

Hastings Technology Metals has agreed to sell its Western Australian gold assets to Metal Bank Limited for A$2.3 million in shares, enabling a sharper focus on its flagship rare earths project. The deal includes key management moves and an in-specie share distribution to Hastings shareholders.

Critical Resources has acquired 90% of the Rock and Pillar prospecting permit, consolidating a strategic 10km strike along the prospective Cap Burn Fault in New Zealand ahead of a planned drill program.

Rox Resources has appointed Byrnecut Australia as the underground mining contractor for its Youanmi Gold Project, marking a key step toward production. The two-part contract will see initial exploration decline development followed by full-scale mining upon a positive investment decision.

MPower Group has finalized the sale of nearly all its assets to Wollemi Energy Group for about $19 million, setting the stage for a potential capital return or a new business acquisition.

Global Lithium Resources Limited has clarified that recent spikes in its share price and trading volume are linked to previously announced project developments, not undisclosed information.

News Corporation has priced a significant secondary offering of over 14 million Class B shares at $32.45 each, marking a notable move by key Murdoch family trusts. The company itself is not raising capital, with proceeds going solely to selling stockholders.

Beacon Minerals has secured critical regulatory approvals for the Iguana Deposit, setting the stage for mining operations and a comprehensive five-year resource development strategy.

Rumble Resources has launched a $9 million capital raise to accelerate development at its Western Queen gold and tungsten projects, targeting near-term production by late 2026. The company also highlights significant resource upgrades and seeks partners for its Earaheedy base metals project.

Rumble Resources has raised $9 million through a combination of institutional placement and entitlement offer to advance its Western Queen gold and tungsten project, targeting production by mid-2026.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Cosmo Metals has received regulatory approval to commence its first-ever drilling program at the Spring Creek prospect within the Bingara Project, aiming to unlock high-grade gold potential along a historically underexplored 12km trend.

Genesis Minerals has secured regulatory approval for Stage One mining at Tower Hill, aligning the project with its mill expansion plans and setting the stage for production in FY28.